top of page
Rinnit logo – modern health products and health news

Leber’s Congenital Amaurosis: Symptoms, Genetic Causes, and Support

3 days ago
5 min read

Updated: 2 days ago

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: September 2026

Leber’s congenital amaurosis (LCA) is a rare and complex eye disease that affects the development and function of the retina in infants. As a congenital condition, it is present from birth, although symptoms may not always be immediately apparent to parents. The disease is characterized by significant vision impairment that is often progressive, meaning the quality of sight tends to decline as the child grows.

For families navigating this diagnosis, understanding the nature of LCA is the first step toward effective management. While the impact on vision can be severe—with one in three infants born with total blindness—modern medical advancements are providing new pathways for support and, in some specific cases, targeted treatments.

Recognizing the Symptoms

The signs of Leber’s congenital amaurosis can vary significantly between individuals. Some infants exhibit complete blindness from birth, while others may show symptoms around six months of age. One of the most common early indicators is a child frequently rubbing or poking at their eyes, even when they are not tired.

Other physical symptoms often associated with the condition include misaligned eyes, also known as strabismus, and an intense sensitivity to light, referred to as photophobia. Parents may also notice involuntary shaking of the eyes, known as nystagmus, or a missing pupillary response where the eyes do not adjust normally to changes in lighting conditions.

The Genetic Basis of LCA

Leber’s congenital amaurosis is primarily a genetic condition caused by variations in the genes responsible for retina development. These variations disrupt the process by which light-detecting cells, or photoreceptors, convert light into electrical signals for the brain to interpret as images. When these signals are weakened, the result is a significant loss of sight.

Overview of retina function in a healthy eye versus one affected by Leber’s Congenital Amaurosis, showing diminished electrical signals.

Key Gene Variations

Role in LCA

RPE65

Involved in the visual cycle; a primary target for current gene therapy.

CEP290

Affects the structure and function of photoreceptor cells.

CRB1

Essential for maintaining the structure of the retina.

GUCY2D

Critical for the electrical response of photoreceptors to light.

LCA is typically inherited in an autosomal recessive pattern, meaning both biological parents must carry at least one copy of the changed gene. Researchers have identified variations in nearly 30 different genes that can lead to the development of this condition.

Infographic illustrating the autosomal recessive inheritance pattern of Leber’s Congenital Amaurosis.

Diagnostic Procedures

A diagnosis of Leber’s congenital amaurosis is typically made by an eye care specialist, such as a pediatric ophthalmologist. The process involves a comprehensive eye exam to inspect the internal structures of the eye. Several specialized tests are used to confirm the diagnosis and assess the extent of the vision loss.

Diagnostic Test

Purpose

Electroretinography (ERG)

Measures the electrical activity and response of the retina to light.

Optical Coherence Tomography (OCT)

Uses reflected light to create detailed images of the back of the eye.

Differential Diagnosis

Ruling out other conditions like color blindness, ptosis, or Zellweger syndrome.

Management and Treatment Options

Currently, there is no universal cure for Leber’s congenital amaurosis. Management focuses on maximizing the remaining vision and supporting the child’s development. For children with some level of sight, specialists often recommend low-vision aids such as high-powered eyeglasses, magnifying glasses, and reading prisms to assist with daily tasks.

A significant breakthrough in treatment is the development of gene therapy. This approach involves replacing diseased or inactive genes with healthy copies. Currently, gene therapy is a viable option for children who carry a specific variation of the RPE65 gene. As research continues, the hope is that similar therapies will be developed for other genetic variations of the disease.

Visual representation of the gene therapy process for LCA, showing the introduction of a healthy RPE65 gene into a retinal cell.

Outlook and Long-Term Support

Because LCA is a progressive condition, regular eye exams are essential to track changes in vision and adjust support strategies. Early intervention services play a crucial role in helping children with blindness or low vision develop the skills they need to navigate the world independently.

Connecting with support groups can also provide invaluable emotional and practical assistance for families. Since LCA is rare, these communities offer a space to share experiences with others who truly understand the challenges of raising a child with significant vision loss.

Conclusion

A diagnosis of Leber’s congenital amaurosis presents lifelong challenges for both the child and their family. However, with early intervention, appropriate low-vision aids, and the potential for targeted genetic treatments, children with LCA can lead fulfilling lives. The focus remains on providing the necessary support to help every child navigate their world with confidence.

Call to Action

If you notice your infant frequently poking at their eyes or if they seem unusually sensitive to light, schedule an appointment with a pediatric eye care specialist immediately. Early diagnosis is the key to accessing the support services and treatments that can make a meaningful difference in your child's future.

Frequently Asked Questions

1. Is Leber’s congenital amaurosis present at birth?

Yes, the term "congenital" means the condition is present from the time of birth, although symptoms may become more obvious as the infant grows.

2. Does LCA always lead to complete blindness?

Not always. While one in three infants with LCA is born blind, others have low vision that typically gets worse over time.

3. What causes Leber’s congenital amaurosis?

It is caused by inherited genetic variations that affect how the retinas in a baby's eyes develop and function.

4. Can LCA be cured?

There is currently no universal cure, but gene therapy is an effective treatment for specific genetic variations, such as those involving the RPE65 gene.

5. What is the most common early sign of LCA?

Frequent rubbing or poking at the eyes, even when the baby is not tired, is a common early symptom.

6. How is LCA inherited?

It is usually inherited in an autosomal recessive pattern, meaning both parents carry the genetic variation.

7. What is an ERG test?

Electroretinography (ERG) is a test that measures the electrical activity of the retina to see how well it responds to light.

8. Are there different types of LCA?

LCA is categorized by the specific gene variation involved; nearly 30 different genes have been linked to the condition.

9. What are low-vision aids?

These include tools like magnifying glasses, reading prisms, and specialized eyeglasses designed to help individuals make the most of their remaining sight.

10. Is LCA the same as retinitis pigmentosa?

No, they are different conditions, though they both affect the retina. An eye specialist will perform a differential diagnosis to distinguish between them.

11. Does LCA affect both eyes?

Yes, Leber’s congenital amaurosis typically affects the retinas in both eyes.

12. Can gene therapy help everyone with LCA?

Currently, gene therapy is only available for specific genetic variations, most notably the RPE65 gene.

13. What is nystagmus?

Nystagmus is a condition where the eyes shake or move involuntarily, which is a common symptom of LCA.

14. Why is early intervention important?

Early intervention services help children with vision loss develop essential navigation and learning skills from a young age.

15. Should I get genetic testing if my child has LCA?

Yes, genetic testing is crucial to identify the specific gene variation, which can determine if the child is a candidate for treatments like gene therapy.

Medical Disclaimer

The information provided in this article is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here.

Recent Posts

See All

Comments


bottom of page